-
Mashup Score: 14
20% of patients treated with Rinvoq achieved 90% or greater reduction on the Eczema Area and Severity Index (EASI) and attained a 0 or 1 grade on the Worst Pruritis Numerical Rating Scale (WP-NRS) compared to 9% of patients treated with Dupixent. The rate of serious adverse events was 0.9% for both Rinvoq and Dupixent.
Source: www.2minutemedicine.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Joint inpatient palliative care approaches may reduce length of stay in intensive care units | 2 Minute Medicine - 3 month(s) ago
1. A joint Inpatient palliative Care (IPC) approach was effective at reducing patients’ time in the intensive care unit (ICU) and hospital overall. Evidence Rating Level: 2 (Good) Patients in the intensive care unit (ICU) would benefit from having an Inpatient Palliative Care (IPC) team to help them through this difficult chapter in their lives.
Source: www.2minutemedicine.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Mobile application communication may improve palliative care needs met in critically ill patients | 2 Minute Medicine - 4 month(s) ago
1. Families randomized to having access to a mobile application that allowed them to communicate needs with intensive care unit (ICU) physicians were found to have reduced unmet palliative care needs compared to usual care. 2. White families were observed to benefit more from the intervention than Black families as measured by the Needs at
Source: www.2minutemedicine.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Computed Tomography coronary calcium scores may predict risk of cardiovascular events in cancer patients | 2 Minute Medicine - 4 month(s) ago
1. Despite lower prevalence of traditional cardiovascular risk factors, cancer patients were observed to have similar cardiovascular disease (CVD) events ot non-cancer counterparts. 2. Coronary artery calcium score (CACS) were well correlated with CVD risk in cancer patients suggesting a potential role as a targeted screening tool. Evidence Level Rating: 2 (Good) To date, cancer
Source: www.2minutemedicine.comCategories: General Medicine News, Partners & KOLsTweet
#Rinvoq, a monoclonal antibody targeting the JAK enzyme, shows better effectiveness in patients with atopic dermatitis compared to Dupixent. #AtopicDermatitis #TreatmentOptions https://t.co/2z7Vo8MkFY https://t.co/xh71jxG0Ma